SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?


To: BigKNY3 who wrote (6977)2/10/1999 7:30:00 AM
From: Joe Dancy  Respond to of 9523
 
EquityTrader has PFE as a "buy" for potential - John Bollinger uses fuzzy logic models to come up with his ratings - and the money flow has been into the stock for quite some time now.

FWIW, his site is at equitytrader.com and you can listen to him walk through analyzing data at his site with SI's Mark Johnson at audioinvestor.com

I'm not really into technical analysis, but it is always nice when the models agree with your fundamental analysis of a company.



To: BigKNY3 who wrote (6977)2/10/1999 12:54:00 PM
From: Anthony Wong  Read Replies (1) | Respond to of 9523
 
Pfizer Inc. Reiterated 'Buy' at PaineWebber
Bloomberg News
Feb 10 1999 10:08AM ET

Princeton, New Jersey, Feb. 10 (Bloomberg Data) -- Pfizer Inc. (PFE US) was reiterated ''buy'' by analyst Jeffrey Chaffkin at PaineWebber Inc. The 12-month target price is $156.00 per share.

-- Andrew Bekoff in Princeton, New Jersey, (609)279-3652